Pharmacology of Heart Failure: Beta Blockers and SGLT2 Inhibitors
From the Pharmacology curriculum
TL;DR
Heart failure medications aim to improve symptoms and prolong life by targeting specific pathways. Beta blockers reduce sympathetic overactivity, while SGLT2 inhibitors offer a new approach by improving kidney and heart function. Understanding their mechanisms helps you grasp why they're crucial in treating heart failure.
1. The Mental Model
Think of heart failure as a car engine that's struggling. Beta blockers help by reducing the engine's stress (slowing heart rate, decreasing force), while SGLT2 inhibitors are like a new fuel additive that helps the engine run more efficiently and protects other vital parts.
2. The Core Material
Heart failure (HF) is a complex syndrome where the heart can't pump enough blood to meet the body's needs. This leads to activation of various compensatory mechanisms that, over time, actually worsen the condition. Two key drug classes, beta blockers and SGLT2 inhibitors, are cornerstones of modern HF treatment.
Beta Blockers

Photo by Marta Branco on Pexels
Beta blockers primarily work by blocking the effects of adrenaline (epinephrine) and noradrenaline (norepinephrine) on beta-adrenergic receptors. In heart failure, the body's sympathetic nervous system is overactive, leading to chronic high heart rate, increased contractility, and vasoconstriction. While this initially helps maintain cardiac output, it eventually damages the heart.
-
Mechanism of Action:
- Beta-1 receptor blockade (primarily): These receptors are found mainly in the heart. Blocking them leads to:
- Decreased heart rate: Gives the heart more time to fill with blood.
- Decreased contractility: Reduces the force of each heartbeat, reducing myocardial oxygen demand.
- Decreased renin release: Renin is part of the Renin-Angiotensin-Aldosterone System (RAAS), which contributes to vasoconstriction and fluid retention.
- Beta-2 receptor blockade (some beta blockers): These are found in the lungs and blood vessels. Blocking them can cause bronchoconstriction (why they're cautiously used in asthma) and mild vasoconstriction.
- Alpha-1 receptor blockade (some beta blockers like carvedilol): This adds vasodilatory effects, further reducing afterload (the resistance the heart pumps against).
- Beta-1 receptor blockade (primarily): These receptors are found mainly in the heart. Blocking them leads to:
-
Benefits in HF:
- Reduce mortality and hospitalizations.
- Improve left ventricular ejection fraction (LVEF).
- Reverse cardiac remodeling (the structural changes that occur in the heart due to stress).
-
Key Beta Blockers for HF: Metoprolol succinate (extended-release), Carvedilol, Bisoprolol. These are the ones shown to improve outcomes in HF.
SGLT2 Inhibitors
Sodium-glucose co-transporter 2 (SGLT2) inhibitors were originally developed for type 2 diabetes, but studies surprisingly showed significant cardiovascular benefits in patients with HF, even those without diabetes.
-
Mechanism of Action (in HF): This is complex and not fully understood, but it's thought to involve several pathways:
- Diuretic effect: They block SGLT2 in the kidneys, preventing reabsorption of glucose and sodium. This leads to increased glucose and sodium excretion in urine, causing a mild osmotic diuresis (fluid loss). This reduces preload (the amount of blood returning to the heart) and congestion.
- Cardiorenal protection: They reduce kidney workload, improve kidney oxygenation, and may have direct protective effects on cardiac cells, reducing inflammation and fibrosis.
- Metabolic effects: They shift the heart's metabolism towards using ketones for fuel, which might be more efficient in the failing heart.
- Vascular effects: They may improve endothelial function and reduce arterial stiffness.
-
Benefits in HF:
- Reduce mortality and hospitalizations.
- Improve symptoms and quality of life.
- Slow progression of kidney disease.
-
Key SGLT2 Inhibitors for HF: Dapagliflozin, Empagliflozin.
Here's a diagram illustrating the key effects:
graph TD
A["Heart Failure Progression"] --> B{"Sympathetic Nervous System Overactivity"}
B --> C["Increased Heart Rate & Contractility"]
B --> D["Increased Renin Release"]
C --> E["Increased Myocardial Oxygen Demand"]
E --> F["Cardiac Damage/Remodeling"]
D --> G["Vasoconstriction & Fluid Retention"]
G --> F
H["Beta Blockers"] --> C["Decreased Heart Rate & Contractility"]
H --> D["Decreased Renin Release"]
C --> I["Reduced Myocardial Stress"]
D --> J["Reduced Fluid Retention"]
I --> K["Improved Cardiac Function"]
J --> K
K --> L["Reduced HF Progression"]
M["SGLT2 Inhibitors"] --> N["Kidney: Increased Na+/Glucose Excretion"]
N --> O["Mild Diuresis (Reduced Preload)"]
N --> P["Improved Renal Function"]
O --> K
P --> K
M --> Q["Cardiac Metabolic Shift/Protection"]
Q --> K
K --> L
3. Worked Example
Let's consider a patient, Mrs. Smith, who has chronic heart failure with a reduced ejection fraction (HFrEF). Her heart rate is consistently around 90 bpm at rest, and she experiences significant fluid retention.
- Without medication: Her high heart rate means her heart works harder, and the sympathetic overactivity contributes to fluid buildup, worsening her symptoms and damaging her heart over time.
- Adding a beta blocker (e.g., Metoprolol succinate): The doctor starts her on a low dose and gradually increases it. As the beta blocker takes effect, her heart rate might decrease to 65-70 bpm. This gives her heart more time to fill and reduces the workload, improving its efficiency and potentially reversing some remodeling. She might notice less fatigue and better exercise tolerance.
- Adding an SGLT2 inhibitor (e.g., Dapagliflozin): This medication would cause a mild increase in urination, helping to reduce her fluid retention and swelling in her legs. Beyond that, the SGLT2 inhibitor also provides direct protection to her heart and kidneys, further reducing her risk of hospitalizations and improving her long-term outlook.
The combination of these drugs addresses multiple pathways of heart failure, providing more comprehensive care than either drug alone.
4. Key Takeaways
- Beta blockers reduce the sympathetic nervous system's harmful effects on the heart, decreasing heart rate and contractility, and preventing cardiac remodeling.
- SGLT2 inhibitors provide a unique benefit in heart failure, including mild diuretic effects, improved kidney function, and direct cardiac protective mechanisms, independent of diabetes status.
- The benefits of both drug classes include reduced hospitalizations and improved survival for heart failure patients.
- Gradual titration (slow increase) of beta blockers is crucial to avoid worsening heart failure symptoms initially.
- SGLT2 inhibitors work by blocking glucose and sodium reabsorption in the kidneys, leading to their unique cardiorenal benefits.
Common Mistakes to Avoid:
* Starting beta blockers at too high a dose: This can acutely worsen heart failure symptoms due to reduced contractility. Always start low and titrate slowly.
* Stopping beta blockers abruptly: This can lead to rebound tachycardia and worsening heart failure symptoms.
* Failing to consider SGLT2 inhibitors in non-diabetic HF patients: Their benefits extend beyond glycemic control.
* Not monitoring for side effects: Both drug classes have potential side effects (e.g., bradycardia with beta blockers, UTIs/genital mycotic infections with SGLT2 inhibitors).
5. Now Try It
Imagine you're explaining to a family member why their grandparent with heart failure is taking both a beta blocker and an SGLT2 inhibitor. In your own words, briefly describe the primary goal of each medication and how they work together to help the heart.
Success looks like: Clearly explaining one main benefit and mechanism for each drug class in a simple, understandable way, highlighting how they complement each other.
Frequently asked about Pharmacology of Heart Failure: Beta Blockers and SGLT2 Inhibitors
More from Pharmacology
Get the full Pharmacology curriculum
Clone the complete plan to your dashboard for unlimited AI-generated notes, practice quizzes, and a personalised revision schedule.
Save this course free